Transcept Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor ...( PT. RICHMOND Calif. Feb. 7 /- Tra...),Health
Navigation Links
Transcept Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
Date:2/7/2008
PT. RICHMOND, Calif., Feb. 7 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. today announced that Glenn A. Oclassen, Chief Executive Officer & President, will present at the 10th Annual BIO CEO & Investor Conference at the Waldorf-Astoria Hotel in New York City on Tuesday, February 12, 2008 at 10:15 AM Eastern Time.
About Transcept Pharmaceuticals
Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company
deriving significant new patient benefits from proven CNS drugs. Transcept
development projects leverage new understanding of CNS conditions to
provide additional uses and enhanced clinical benefits for existing active
agents. The lead Transcept product, Intermezzo(R) (zolpidem tartrate
lozenge), is a low dose sublingual formulation of zolpidem for the
treatment of insomnia in patients who awaken in the middle of the night and
have difficulty returning to sleep. Phase 3 clinical trials have been
completed for Intermezzo(R) and Transcept plans to submit an NDA in the
third quarter of 2008. Another product being developed by Transcept is
TO-2060, a novel, fixed-dose combination of olanzapine and ondansetron for
the treatment of dopamine associated psychiatric disorders. TO-2060 has
recently completed a successful dose ranging trial for the treatment of
alcohol use disorder and a full clinical development program has begun. For
further information, please visit the company's website at:
http://www.transcept.com.
Contacts:
Transcept Pharmaceuticals, Inc.
Michael Gill
Director of Communications
(510) 215-3575
The Ruth Group
Investors / Media
Stephanie Carrington / Jason Rando
(646) 536-7017 / 7025
| SOURCE Transcept Pharmaceuticals, Inc. Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
2. Transcept Pharmaceuticals, Inc. to Present at 2007 BIO Investor Forum
3. Transcept Pharmaceuticals to Present at 19th Annual Piper Jaffray Health Care Conference
4. Transcept Pharmaceuticals to Present at RBC Capital Markets 2007 Healthcare Conference
5. Transcept Pharmaceuticals to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
6. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
7. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
10. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
11. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
Post Your Comments:
(Date:11/30/2009)... Firm uses Staten Island courtroom to recreate ...were 100% responsible for client’s accident.... November 30, 2009 -- A Staten Island, N.Y. jury a...aperhanger who was injured at a New York City cons... J.T. Magen Construction Company et al (Index No. ...
(Date:11/30/2009)...ELAND, Ohio, November 30 Simbionix... medical simulation systems, in collaboration,with...e Rehearsal Studio(TM),workshop for the first time...y. , The Simbionix PROcedure Rehearsal St... enable clinicians to create practice scenarios ba...
(Date:11/30/2009)...y is an effective, convenient technique that, when...cerous breast lesions from benign results, accordi...al meeting of the Radiological Society of North Am...us findings, physicians often use ultrasound to ob...as the potential to result in more biopsies becaus...
(Date:11/29/2009)... The Academy of General Dentistry (AGD) announc...eived the Mastership Award during the AGD,s commen...mmitment to excellence in dental education.,To ac... approved continuing dental education in the 16 di...ted to hands-on skills and techniques. , ...
(Date:11/29/2009)...00 round of treatment equals a $41,000 pay raise, ...ealthDay News) -- Psychological therapy may be muc...ng a raise or winning a lottery prize, suggests an...thousands of people who provided information about...se in happiness from a $1,329 course of therapy wa...
Breaking Medicine News(10 mins):Health News:Raphaelson & Levine Secures $1.1 Million Verdict for Victim of New York Construction Accident 2Health News:Simbionix First Procedure Rehearsal Studio(TM) Training Workshop 2Health News:Simbionix First Procedure Rehearsal Studio(TM) Training Workshop 3Health News:Elastography reduces unnecessary breast biopsies 2Health News:Orange County Dentist Honored by The Academy of General Dentistry 2Health News:Psychotherapy Can Boost Happiness More Than Money: Study 2[0] Raphaelson & Levine Secures $1.1 Million Verdict for Victim of New York Construction Accident[0] Simbionix First Procedure Rehearsal Studio(TM) Training Workshop[0] Elastography reduces unnecessary breast biopsies[1] Orange County Dentist Honored by The Academy of General Dentistry [0] Psychotherapy Can Boost Happiness More Than Money: Study
...rs from the Northwestern University are developing... off a gene involved in Parkinson's disease. Marth...University Feinberg School of Medicine designed th...hn and her team involves turning off alpha-synucle...
...rs at the University of North Carolina (UNC) at Ch...aline is good for the lungs of patients affected b...water-based salt solution with excess concentratio...salt solution improved the health of the lungs and...
...nnell works as a part of Australia's health system...rained to attend to patients without the guidance ...h as X-rays, treat them for minor problems,// pres...tralia is not well recognized. Statistics reveal t...
...s 1.107 million fowl have been killed in Turkey wi...flu infection in the country. This has been reveal... Bird Flu. //The infection has been detected in as...din, Bursa, Istanbul, Bitlis, Yozgat, Ankara, Sanl...
...ajor Philip Morris is being sued by four Marlboro ...detection of lung cancer. The four people are dema...ch is estimated at ?300. //If this were to be brou...rketing to encourage smoking.
A class actio...
... behavioral therapy may prove to be as beneficial ...as physical therapy. This has been revealed by a D.../ has been reported by patients who underwent thes...benefits by way of relief.
Dr. Rob Smeets o...
Other Medicine News:Health News:Nurse Practitioners Are Not Recognized By Medicare 2Health News:Nurse Practitioners Are Not Recognized By Medicare 3Genetic Therapy Could Solve Parkinson’s PuzzlInhaling Concentrated Saline Could Benefit Cystic Fibrosis PatientsNurse Practitioners Are Not Recognized By MedicareTurkey Gears Itself To Fight Bird FluSmokers Sue Tobacco Major Philip MorrisCognitive Behavioral Therapy Seen To Be Effective Against Back Pain
(Date:11/27/2009)...LOOMINGTON, Minn, Nov. 27 ACUO TEC...image management software, data migration tools an... States Patent and Trademark Office has approved a...rmat within a Computer Network." Acuo Technologies...o of intellectual property. In general, the grante...
(Date:11/25/2009)..., LOVELAND, Colo., Nov. 25 /PRNewswire-FirstCall/...g provider of advanced diagnostic and specialty ...ay agreements with Roche Diagnostics Corporation f... consumables for the veterinary market. ,, (...22/HESKALOGO ) ,, "Heska and Roche share the sa...
(Date:11/25/2009)... EXTON, Pa., Nov. 25 BioTrends Res...rends(TM) : Stelara report, the first in a mu...ing the launch of Centocor Ortho-Biotech,s Stelara... of availability. Each wave of the report provide...ogists and qualitative information from a subset o...
Breaking Medicine Technology:Acuo Technologies Announces Patent for Asset Communication Format Within a Computer Network 2Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Fructose Boosts Blood Pressure Studies Find 58246 1Fructose Boosts Blood Pressure Studies Find 58246 2Fructose Boosts Blood Pressure Studies Find 58246 3The American Fertility Association Responds to Alleged Embryo Mix Up Case in Ohio 58243 1The American Fertility Association Responds to Alleged Embryo Mix Up Case in Ohio 58243 2The American Fertility Association Responds to Alleged Embryo Mix Up Case in Ohio 58243 330th Anniversary Edition of Mandell Douglas and Bennetts Principles and Practice of Infectious Diseases is More Relevant Than Ever 58240 130th Anniversary Edition of Mandell Douglas and Bennetts Principles and Practice of Infectious Diseases is More Relevant Than Ever 58240 230th Anniversary Edition of Mandell Douglas and Bennetts Principles and Practice of Infectious Diseases is More Relevant Than Ever 58240 330th Anniversary Edition of Mandell Douglas and Bennetts Principles and Practice of Infectious Diseases is More Relevant Than Ever 58240 4...vement with Lower Doses of,Dexamethasone, the Ster... Newly Diagnosed Myeloma -, NORTH HOLLYWOOD, Calif...l Myeloma Foundation (IMF) - supporting research a...yeloma patients,families, researchers and physici...ng the dose of the steroid dexamethasone when,trea...
...ny Oncology Programs to be Presented, SOUTH SAN FR...all/ -- Cytokinetics, Incorporated announced,today...ll be,presented at the 2007 Annual Meeting of the ... be held from April 14- 18, 2007 in,Los Angeles, C...programs at Cytokinetics and will present data eva...
Other Medicine Technology:The International Myeloma Foundation Says New Clinical Trial,Results Could Improve Survival While Reducing Side Effects For Many,Patients 2The International Myeloma Foundation Says New Clinical Trial,Results Could Improve Survival While Reducing Side Effects For Many,Patients 3Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 2Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 3Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 4Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 5Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 6Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 7...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
Medicine Products:| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |